Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 145.00
Bid: 144.00
Ask: 146.50
Change: -5.00 (-3.33%)
Spread: 2.50 (1.736%)
Open: 150.00
High: 150.00
Low: 145.00
Prev. Close: 150.00
BIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to press speculation

29 Jan 2024 07:05

RNS Number : 1932B
Big Technologies PLC
29 January 2024
 

29 January 2024

Big Technologies plc

("Big Technologies" or the "Company")

 

Response to press speculation

 

In response to the article published in The Times on 29 January 2024 (the "Article") regarding the claim as filed with the High Court of Justice England and Wales on 2 August 2023 (and amended and re-filed on 22 November 2023) (the "Claim"), brought by Philippa D'Arcy, Michael and Rhian-Anwen Hamill, Mark Hawtin and Brian Maclaurin, former shareholders of Buddi Limited (representing around 6% of the fully diluted share capital of Buddi Limited in May 2018), the Company reiterates the position set out in the RNS announcement dated 4 August 2023.

 

The Company wishes to make it clear that the particulars of claim as set out in the Article regarding the existence of "undisclosed interests" of Sara Murray in certain of its shareholders are wholly untrue.

 

The Company has taken advice from its lawyers and from King's Counsel and remains confident that the Claim lacks legal and factual merit and intends to defend its position robustly. 

 

The Company will make further announcements regarding the Claim as appropriate.

 

For further information please contact:

 

Big Technologies

via Williams Nicolson

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

 

 

Williams Nicolson (PR Advisers)

Steffan Williams steffan.williams@williamsnicolson.com 

William Barker william.barker@williamsnicolson.com

+44 (0) 7767 345563

+44 (0) 7534 068657

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Jamie Peel / Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

Background

 

As set out within the admission document in July 2021 (the "Admission Document"), a letter of potential claim had been received from Philippa D'Arcy, Michael and Rhian-Anwen Hamill, Mark Hawtin and Brian Maclaurin, former shareholders of Buddi Limited (representing around 6% of the fully diluted share capital of Buddi Limited in May 2018), one of the subsidiaries of the Group, in respect of the operation of a drag mechanism contained in the articles of Buddi Limited that was utilised in connection with the acquisition of Buddi Limited, dating back to May 2018.

 

As was set out on page 138 of the Admission Document, the Company sought legal advice from a number of sources, including solicitors who advised the Company on the operation of the drag mechanism, its solicitors on the placing at IPO and Queen's Counsel. The conclusions were, that having reviewed that advice (which is the subject of legal privilege which is not waived), that the Company is satisfied that the drag mechanism was exercised properly in accordance with its terms and that any claim brought by the former Buddi Limited shareholders would be likely to be defeated.

 

 The Company will make further announcements regarding the Claim as appropriate.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCEAXFNAELLEEA
12
Date   Source Headline
26th Apr 202411:28 amRNS2023 Annual Report and Notice of AGM
26th Mar 20247:00 amRNS2023 Preliminary audited results
22nd Feb 202411:35 amRNSHolding(s) in Company
5th Feb 20244:25 pmRNSDirector/PDMR Shareholding
29th Jan 20247:05 amRNSResponse to press speculation
26th Jan 202411:07 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSEBT Share Purchase
23rd Jan 20247:00 amRNSDirector/PDMR Shareholding
22nd Jan 20242:23 pmRNSDirector/PDMR Shareholding
22nd Jan 202412:12 pmRNSHolding(s) in Company
19th Jan 20247:04 amRNSTrading Statement
22nd Dec 202311:30 amRNSHolding(s) in Company
21st Dec 20231:35 pmRNSEBT Share Purchase
20th Dec 20232:16 pmRNSDirector/PDMR Shareholding
8th Dec 20233:05 pmRNSDirector/PDMR Shareholding
8th Dec 20237:00 amRNSEBT Share Purchase
6th Dec 20232:06 pmRNSEBT Share Purchase
4th Dec 202312:40 pmRNSEBT Share Purchase
20th Nov 202310:58 amRNSEBT Share Purchase
10th Nov 20239:08 amRNSDirector/PDMR Shareholding
8th Nov 20231:48 pmRNSEBT Share Purchase
1st Nov 20231:42 pmRNSEBT Share Purchase
25th Oct 202310:22 amRNSDirector/PDMR Shareholding
24th Oct 20234:57 pmRNSDirector/PDMR Shareholding - Replacement
24th Oct 202312:23 pmRNSDirector/PDMR Shareholding
24th Oct 202311:55 amRNSDirector/PDMR Shareholding - Replacement
23rd Oct 20235:05 pmRNSDirector/PDMR Shareholding
23rd Oct 20235:03 pmRNSEBT Share Purchase
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20239:05 amRNSIncrease in Share Capital
11th Oct 20231:40 pmRNSEBT Share Purchase
10th Oct 202311:40 amRNSEBT Share Purchase
3rd Oct 20237:00 amRNSEBT Share Purchase
28th Sep 20237:00 amRNSEBT Share Purchase
21st Sep 20237:00 amRNSEstablishment of an Employee Benefit Trust
19th Sep 20237:00 amRNSHalf-year Report
4th Aug 20238:57 amRNSStatement re legal claim
18th Jul 20237:00 amRNSIncrease in share capital and director dealing
7th Jun 20237:00 amRNSIncrease in share capital
23rd May 20231:43 pmRNSResult of AGM
23rd May 20237:00 amRNSAGM Statement
17th May 20232:10 pmRNSIncrease in Share Capital
26th Apr 20231:40 pmRNS2022 Annual Report and Notice of AGM
21st Apr 202310:27 amRNSDirector/PDMR Shareholding
5th Apr 20231:04 pmRNSDirector/PDMR Shareholding
4th Apr 202312:27 pmRNSDirector/PDMR Shareholding
31st Mar 202312:12 pmRNSIncrease in Share Capital
29th Mar 20237:00 amRNS2022 Preliminary audited results
23rd Mar 20231:01 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.